Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jung-min Lee
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
398 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arthur J E Child Comprehensive Cancer Centre
Calgary, Alberta, Canada
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Royal Victoria Regional Health Centre
Barrie, Ontario, Canada
- Juravinski Cancer Centre at Hamilton Health Sciences
Hamilton, Ontario, Canada
- Kingston Health Sciences Centre
Kingston, Ontario, Canada
- London Regional Cancer Program
London, Ontario, Canada
- Algoma District Cancer Program Sault Area Hospital
Sault Ste. Marie, Ontario, Canada
- Odette Cancer Centre- Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
- University Health Network-Princess Margaret Hospital
Toronto, Ontario, Canada
- Chum - Centre Hospitalier de L'Universite de Montreal
Montreal, Quebec, Canada
- Ciusssemtl-Hopital Maisonneuve-Rosemont
Montreal, Quebec, Canada
- Jewish General Hospital
Montreal, Quebec, Canada
- Chu de Quebec-L'Hotel-Dieu de Quebec (hdq)
Québec, Quebec, Canada
- Ehime University Hospital
Tōon, Ehime, Japan
- Hokkaido University Hospital
Sapporo, Hokkaido, Japan
- Kagoshima City Hospital
Kagoshima, Kagoshima-ken, Japan
- the Cancer Institute Hospital of Jfcr
Koto-ku, Tokyo, Japan
- Kindai University
Osaka, Japan
- Saitama Medical University International Medical Center
Saitama, Japan
- National Cancer Center Hospital
Tokyo, Japan
- Centro Comprensivo de Cancer de Upr
San Juan, Puerto Rico
- Keimyung University-Dongsan Medical Center
Dalseo-gu, Daegu, South Korea
- Seoul National University Bundang Hospital
Seongnam, Kyeonggi-do, South Korea
- Gachon University Gil Hospital
Incheon, South Korea
- Asan Medical Center
Seoul, South Korea
- Gangnam Severance Hospital
Seoul, South Korea
- Korea Cancer Center Hospital
Seoul, South Korea
- Kyung Hee University Hospital at Gangdong
Seoul, South Korea
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Alaska Women'S Cancer Care
Anchorage, Alaska, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Sutter Auburn Faith Hospital
Auburn, California, United States
- Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California, United States
- Mercy San Juan Medical Center
Carmichael, California, United States
- Mercy Cancer Center - Elk Grove
Elk Grove, California, United States
- Marin Cancer Care Inc
Greenbrae, California, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- Palo Alto Medical Foundation-Camino Division
Mountain View, California, United States
- Palo Alto Medical Foundation-Gynecologic Oncology
Mountain View, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 May 2016
- Primary completion
- 12 Jun 2023
- Completion
- 4 Mar 2027
- Last update posted
- 1 Jul 2026
- Registered enrollment
- 582
- Registry id
- NCT02502266
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.